Global Knowledge-based/Evidence based Clinical decision support systems (CDSS) Market Research Report
- Report Code: KN 1000
- Publish Date: Upcoming
The global knowledge-based clinical decision support systems (CDSS) market was valued at $245 million in 2012, and is expected to reach $418 million by 2018, at a CAGR of 9.6%.
The report ‘Knowledge-based Clinical decision support systems (CDSS) Market forecast, 2012-2020’ analyzes the market by sub-segments, such as integrated knowledge-based CDSS and standalone knowledge-based CDSS. Integrated CDSS accounts for about 70% of the total market. The knowledge-based CDSS market can also be segmented based upon components into hardware, software, and services.
North America is the global leader in the knowledge-based CDSS market, due to the rapid advancements in technology, and higher awareness rate among patients. North America is a huge market, accounting 70% of the global knowledge-based CDSS market. This is followed by Europe with a market share of 14% and Asia with a market share of 7%.
The major driver for the knowledge-based CDSS market is the increasing demand for analytical IT solutions that help in point-of-care decision making. The implementation of such solutions has resulted in the cost reduction of these clinical software, and improvement in the quality of patient care. Other factors responsible for the growth of this market are the increasing government initiatives and introduction of various incentive plans for healthcare providers.
The report also provides an extensive competitive landscaping of companies operating in this market. Meditech is the market leader followed by major players, such as Cerner Corporation, Athenahealth, Inc., McKesson Corporation, and Zynx Health Incorporated.
Segment and country specific company shares, news & deals, mergers and acquisitions, segment specific pipeline products, product approvals, and product recalls of the major companies have been discussed in this report.
Customization Options
Along with the market data, you can also customize MMM assessments that meet your company’s specific needs. Customize to get comprehensive industry standard and deep dive analysis of the following parameters:
Product Analysis
- Usage pattern (in-depth trend analysis) of products (segment wise)
- Product matrix, which gives a detailed comparison of product portfolio of each company mapped at country and sub-segment level
- End-user adoption rate analysis of the products (segment wise and country wise)
Procedure Volume Data
- Number of software installed
- End-users
Surgeons/Physicians Perception Matrix
- Fast turn-around analysis of surgeons’ response to market events and trends
- Pattern analysis of usage of devices by physicians
- Surgeons’ opinion about products from different companies
Brand Perception Matrix
- Comprehensive study of customer perception and behavior through our inbuilt social connect tool, by checking the virality and tonality of blogs
- Analysis of overall brand usage and familiarity, along with brand advocacy distribution (detractor/neutral/familiar)
1 Introduction
1.1 Analyst Insights
1.2 Market Definitions
1.3 Market Segmentation & Aspects Covered
1.4 Research Methodology
2 Executive Summary
3 Market Overview
4 By Applications
4.1 Clinical Guidelines
4.2 Clinical Reminders
4.3 Drug Allergy Alerts
4.4 Drug-Drug Interactions
4.5 Drug Dosing Support
5 By Components
5.1 Hardware (Healthcare IT)
5.2 Software (Healthcare IT)
5.3 Services (Healthcare IT)
6 By Deployments
6.1 On-premise
6.2 Web-based
6.3 Cloud-based
7 By Endusers
7.1 Office based Physicians
7.2 Hospitals
7.3 Emergency Healthcare Service providers
7.4 Nurses
8 By Products
8.1 Integrated Knowledge-based/Evidence based CDSS
8.2 Standalone Knowledge-based/Evidence based CDSS
9 By Geographies
9.1 North America
9.2 Europe
9.3 Asia
9.4 Rest of World
10 By Companies
10.1 Cerner Corporation
10.2 Epic Systems
10.3 McKesson Corporation
10.4 Philips Healthcare
10.5 Elseveir Business Segments
10.6 Wolters Kluwer
10.7 Zynx Health, Inc
10.8 Eclipsys
10.9 Meditech
10.10 Thomson Reuters
10.11 Athenahealth
10.12 Other Companies
Please fill in the form below to receive a free copy of the Summary of this Report
Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
| PRODUCT TITLE | PUBLISHED | |
|---|---|---|
|
|
North American Knowledge-based/Evidence based Clinical decision support systems (CDSS) The North American Knowledge-based Clinical decision support systems (CDSS) market was estimated at $177 million in 2012, and is projected to reach $283 million by 2018, at a CAGR of 8.1%.The knowledge-based CDSS market can be segmented by geography, application, technology, product, and end-users. Deep dive analysis of top players of this market have also been considered in this report. |
Upcoming |
|
|
European Knowledge-based/Evidence based Clinical decision support systems (CDSS) The European Knowledge-based Clinical decision support systems (CDSS) market was valuated at $36 million in 2012, and is expected to reach $56 million by 2018, growing at a CAGR of 7.4%.The Knowledge-based CDSS market can be segmented by geography, application, technology, product, and end-user. Deep dive analysis of key market players have also been considered in this report. |
Upcoming |
|
|
Asian Knowledge-based/Evidence based Clinical decision support systems (CDSS) The Asian Knowledge-based CDSS Market was estimated at $19.9 million in 2012, and is anticipated to reach $31 .6million by 2018, at a CAGR of 8.5%.The Knowledge-based CDSS market can be segmented by geography, application, technology, product, and end-user. Deep dive analysis of the top market players have also been considered in this report. |
Upcoming |
